These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17666364)

  • 41. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
    Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
    Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
    Vetro C; Haferlach T; Jeromin S; Stengel A; Zenger M; Nadarajah N; Baer C; Weissmann S; Kern W; Meggendorfer M; Haferlach C
    Br J Haematol; 2018 Oct; 183(1):47-59. PubMed ID: 30022491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
    Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.
    Maura F; Cutrona G; Fabris S; Colombo M; Tuana G; Agnelli L; Matis S; Lionetti M; Gentile M; Recchia AG; Di Raimondo F; Musolino C; Ilariucci F; Di Renzo N; Pesce E; Molica S; Federico M; Cortelezzi A; Morabito F; Ferrarini M; Neri A
    PLoS One; 2011; 6(8):e24313. PubMed ID: 21897877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.
    Sagatys EM; Zhang L
    Cancer Control; 2012 Jan; 19(1):18-25. PubMed ID: 22143059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
    Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients.
    Doneda L; Montillo M; Intropido L; Tedeschi A; Morra E; Larizza L
    Cancer Genet Cytogenet; 2003 Jan; 140(1):31-6. PubMed ID: 12550755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of immunoglobulin variable heavy chain gene mutation status: long term follow-up in a series of chronic lymphocytic leukemia patients.
    Panovska-Stavridis I; Cevreska L; Stojanovic A; Efremov D
    Prilozi; 2006 Dec; 27(2):127-37. PubMed ID: 17211297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [News in therapeutic management of chronic lymphoid leukemia].
    Michallet AS; Salles G; Coiffier B; Michallet M
    Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
    Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
    Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
    Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
    Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
    Kriangkum J; Motz SN; Mack T; Beiggi S; Baigorri E; Kuppusamy H; Belch AR; Johnston JB; Pilarski LM
    PLoS One; 2015; 10(9):e0137232. PubMed ID: 26353109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
    Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
    Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome.
    Timár B; Fülöp Z; Csernus B; Angster C; Bognár A; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2004 Feb; 18(2):326-30. PubMed ID: 14671632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.
    Vasconcelos Y; Davi F; Levy V; Oppezzo P; Magnac C; Michel A; Yamamoto M; Pritsch O; Merle-Béral H; Maloum K; Ajchenbaum-Cymbalista F; Dighiero G
    J Clin Oncol; 2003 Nov; 21(21):3928-32. PubMed ID: 14581416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
    Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
    Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.